Anastomosis Devices - Market Insights, Competitive Landscape, and Market Forecast - 2030

Anastomosis Device Market by Product (Surgical Staplers, Surgical Sutures, Surgical Sealants, and Surgical Adhesives), Usability (Disposable and Reusable), Application (Cardiovascular Surgery, Gastrointestinal Surgery, and Others), End-User (Hospitals & Clinics, Ambulatory Surgical Centers, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World) is expected to advance at a substantial CAGR forecast till 2030 owing to the increasing instances of chronic disorders and the rising product developmental activities worldwide

The anastomosis devices market is projected to grow at a 5.3% CAGR during the forecast period from 2024 to 2030. The anastomosis devices market is growing significantly due to the increasing cases of colorectum cancers, coronary artery disease (CAD) among the population, clearances from regulatory bodies, and the growing burden of surgeries are factors that are expected to escalate the overall growth of the anastomosis devices market during the forecast period from 2024 to 2030.

Anastomosis Devices Market Dynamics:

Data from the Global Cancer Observatory 2024, stated that in the year 2022 there were about 1926425 total colorectum cancer cases worldwide. The same source further stated that Asia accounted for 966399 colorectum cancer cases, comprising almost 50% of the total cases, and Europe accounted for 538262 colorectum cancer cases. The high incidence of colorectal cancer globally drives the demand for surgical treatments, where anastomosis devices play a critical role in resecting and reconnecting the colon. These devices enhance surgical precision, reduce complications, and improve patient outcomes, making them indispensable in colorectal cancer surgeries and expanding their market presence.

According to British Heart Foundation, Global Heart & Circulatory Diseases Factsheet (2024), it stated that around 200 million people are currently living with CAD around the world. Anastomosis devices enhance precision and efficiency in procedures like coronary artery bypass grafting (CABG), improving patient outcomes and reducing complications, making them increasingly integral to CAD treatment.

Increased product development activities by regulatory bodies are also slated to witness market growth for anastomosis devices. For example, in January 2023, Lydus Medical announced that its Vesseal microvascular anastomosis suture deployment system received 510(k) clearance from the US Food and Drug Administration (FDA).

Hence, the interplay of all the above-mentioned factors are expected to drive the market for anastomosis devices market during the given forecast period from 2024 to 2030.

However, complications due to anastomosis, and the increasing demand for minimally invasive or non-invasive treatment approach, among others may restrict the market growth of anastomosis devices.

Anastomosis Devices Market Segment Analysis:

Anastomosis Device Market by Product (Surgical Staplers, Surgical Sutures, Surgical Sealants, and Surgical Adhesives), Usability (Disposable and Reusable), Application (Cardiovascular Surgery, Gastrointestinal Surgery, and Others), End-User (Hospitals & Clinics, Ambulatory Surgical Centers, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)

In the product segment of the anastomosis devices market, the surgical staplers category is expected to have a significant revenue share in the year 2023. This is primarily owing to the rising focus of manufacturers toward developing technologically advanced surgical staplers for an improved and efficient connection of vessels and the other various advantages offered by the category.

The surgical staplers provide quick placement, minimal tissue reaction, low risk of infection, and strong wound closure in patients with cardiovascular and gastrointestinal diseases. The staplers are also available in different shapes and sizes, easing the process of closure during surgery.

Further, the increasing product launches and regulatory approvals of the anastomosis devices will aid in increasing its demand in the market. For instance, in March 2021, FDA approved Viola clamps, a less proximal anastomosis device, and a new device for clamp proximal anastomosis in coronary artery bypass grafting (CABG).

Therefore, owing to the aforementioned factors, the surgical staplers category is expected to witness considerable growth eventually contributing to the overall growth of the global anastomosis device market during the forecast period.

North America is expected to dominate the overall anastomosis devices market:

Among all the regions, North America is estimated to hold a significant revenue share in the anastomosis devices market. This can be attributed to several factors such as rising colorectum cancer cases, the presence of key market players, combined with significant advancements in product development and regulatory approvals that are acting as key factors contributing to the growth of the anastomosis devices market in the North America region during the forecast period from 2024 to 2030.

According to data from the Global Cancer Observatory 2024, it stated that in the year 2022, there were 183911 total colorectum cancer cases in the region. The same source further stated that the US accounted for 160186 colorectum cancer cases which is almost 87% of the total cases, and Canada accounted for 23725 colorectum cancer cases. Anastomosis devices are essential for reconnecting bowel segments during surgical resections. Advanced devices improve surgical precision, reduce complications, and enhance recovery, making them indispensable in managing colorectal cancer cases and expanding their market.

Additionally, in October 2024, GT Metabolic Solutions Inc., a global leader in magnetic compression anastomosis surgery, announced that the U.S. Food and Drug Administration cleared GT Metabolic's MagDI(TM) System for side-to-side duodeno-ileal (DI) anastomosis.

The prompt and well-established healthcare services and infrastructure further contribute to the growth of the regional anastomosis devices market growth. The presence of key players such as Johnson & Johnson Services, Inc., B.Braun Melsungen AG, and Medtronic with their strong distribution networks ensure widespread availability and accessibility of these devices across the region increasing their revenue shares in the market, and supportive reimbursement programs providing immense growth opportunities for the same.

Therefore, the interplay of all the factors mentioned above would provide a conducive growth environment for the North America region in the anastomosis devices market during the forecast period from 2024 to 2030.

Anastomosis Devices Market key players:

Some the key market players operating in the anastomosis devices market include B. Braun Melsungen AG, Intuitive Surgical, BAXTER, CryoLife, Inc, Johnson & Johnson Services, Inc., Medtronic, Sinolinks Medical Innovation, Inc., microcuremed, BIOWIN PHARMACEUTICAL CO., LIMITED, Waston Medical Corporation, W. L. Gore & Associates, Inc., Hangzhou Demo Medical Technology Co., Ltd, BD, Dolphin Sutures, gpcmedical, Golden Stapler Surgical Co., Ltd., JIANGSU JOYMED TECH CO., LTD, Changzhou Haiers Medical Devices Co., Ltd, Shanghai MedEco Industry Co., Ltd, ChangZhou WeiPu Medical Devices CO., LTD, and others.

Recent Developmental Activities in the Anastomosis Devices Market:

• In April 2021, Ethicon announced the global launch of a new powered surgical stapler, with gripping surface technology.
• In March 2021, Johnson & Johnson launched the ECHELON Stapler, which is a powered surgical stapler designed to reduce complications in surgery through more uniform tissue compression.
• In February 2021, Vascular Graft Solutions Ltd. received a receipt of marketing authorization from the FDA for VIOLA. This is a new device for clampless proximal anastomosis in CABG.

Key takeaways from the Anastomosis Devices market report study

• Market size analysis for current anastomosis devices market size (2023), and market forecast for 6 years (2024 to 2030)
• Top key product/services developments, mergers, acquisitions, partnerships, and joint ventures happened for the last 3 years
• Key companies dominating the anastomosis devices market
• Various opportunities available for other competitors in the anastomosis devices market space
• What are the top-performing segments in 2023? How these segments will perform in 2030?
• Which are the top-performing regions and countries in the current anastomosis devices market scenario?
• Which are the regions and countries where companies should have concentrated on opportunities for anastomosis devices market growth in the coming future?

Target audience who can be benefited from this Anastomosis Devices market report study

• Anastomosis device providers
• Research organizations and consulting companies
• Anastomosis devices-related organizations, associations, forums, and other alliances
• Government and corporate offices
• Start-up companies, venture capitalists, and private equity firms
• Distributors and traders dealing in anastomosis devices
• Various end-users who want to know more about the anastomosis devices market and the latest developments in the anastomosis devices market

Frequently Asked Questions for the Anastomosis Devices Market:

1. What are anastomosis devices?

• The anastomosis device is used for making the surgical connection between two tubular structures, such as blood vessels or loops of the intestine. An anastomosis is a surgical procedure that involves connecting two structures and is performed after the resection of an organ to connect the remaining sections.

2. What is the market for anastomosis devices?

• The anastomosis devices market is projected to grow at a 5.3% CAGR during the forecast period from 2024 to 2030.

3. What are the drivers for the anastomosis devices market?

• The anastomosis devices market is growing significantly due to the increasing cases of colorectum cancers, coronary artery disease among the population, clearances from regulatory bodies, and the growing burden of surgeries are factors that are expected to escalate the overall growth of the anastomosis devices market during the forecast period from 2024 to 2030.

4. Who are the key players operating in the anastomosis devices market?

• Some of the major market players operating in the anastomosis devices market include B. Braun Melsungen AG, Intuitive Surgical, BAXTER, CryoLife, Inc, Johnson & Johnson Services, Inc., Medtronic, Sinolinks Medical Innovation, Inc., microcuremed, BIOWIN PHARMACEUTICAL CO., LIMITED, Waston Medical Corporation, W. L. Gore & Associates, Inc., Hangzhou Demo Medical Technology Co., Ltd, BD, Dolphin Sutures, gpcmedical, Golden Stapler Surgical Co., Ltd., JIANGSU JOYMED TECH CO., LTD, Changzhou Haiers Medical Devices Co., Ltd, Shanghai MedEco Industry Co., Ltd, ChangZhou WeiPu Medical Devices CO., LTD, and others.

5. Which region has the highest share in the anastomosis devices market?

• Among all the regions, North America is estimated to hold a significant revenue share in the anastomosis devices market. This can be attributed to several factors such as the rising colorectum cancer cases, the presence of key market players, combined with significant advancements in product development and regulatory approvals are acting as key factors that contribute to the growth of the anastomosis devices market in the North America region during the forecast period from 2024 to 2030.